Related Experiment Video
Updated: Jul 22, 2026

05:44
In vitro Cell Culture Model for Toxic Inhaled Chemical Testing
Published on: May 8, 2014
10.7K
In Vitro Model of Prepacked Carbon Dioxide Absorber Use: Development and Testing
Jennifer Jouwena1, Delphine Verbeke1, Andre M De Wolf2
1Department of Anesthesiology, Onze Lieve Vrouw Hospital, Aalst, Belgium; Department of Anesthesiology, UZLeuven, Leuven, Belgium; Department of Cardiovascular Sciences, KULeuven, Leuven, Belgium.
Anesthesiology
|December 13, 2023
Summary
New models accurately predict carbon dioxide absorber performance, enabling reduced fresh gas flow during anesthesia. These models quantify canister usage based on carbon dioxide load and ventilation, optimizing anesthetic gas delivery.
Area of Science:
- Anesthesiology
- Respiratory Physiology
- Medical Device Engineering
Background:
- Carbon dioxide (CO2) absorbers are crucial for anesthesia, allowing reduced fresh gas flow (FGF) below minute ventilation (V˙E).
- Accurate performance prediction of CO2 absorbers is essential for safe and efficient anesthetic gas delivery.
- Variability in CO2 load (V˙CO2), FGF, V˙E, and workstation type impacts absorber performance.
Purpose of the Study:
- To develop and validate in vitro models for quantifying CO2 absorber performance.
- To establish a linear relationship between FGF and fractional canister usage (FCU0.5).
- To assess the influence of V˙CO2 and V˙E on CO2 absorber efficiency.
Main Methods:
- Derived a linear relationship between FGF and FCU0.5 based on first principles.
- Developed two basic models and extended them with an empirical workstation factor.
- Tested hypotheses regarding the proportionality of FCU0.5 intercept with V˙CO2 and independence from V˙E.
- Compared measured FCU values against model predictions using Varvel's performance criteria.
Main Results:
- FCU0.5 was found to be proportional to V˙CO2 and independent of V˙E adjustments (P = 0.962) at a fixed FGF of 0.3 L/min.
- The hypothesized parallel shift in the FGF-FCU0.5 relationship was confirmed under varying V˙CO2 and V˙E.
- Both extended models demonstrated good predictive capabilities for canister performance.
Conclusions:
- The developed models effectively predict prepacked CO2 canister performance in vitro.
- These models are applicable across a range of V˙E, FGF, and V˙CO2 encountered in clinical practice.
- Further in vivo validation is recommended to confirm clinical utility.

